First Online: 13 April 2021
: S.A.J. has received research support from GSK, Mestag Therapeutics, Hoffmann la Roche, NovImmune SA, and Ferring Pharmaceuticals, and consultancy from Sanofi-Regeneron, GSK, Janssen, EUSA Pharmaceuticals, NovImmune SA., Chugai Pharmaceutical and Hoffmann la Roche. C.A.H. has received research support from Janssen.
Free to read: This content has been made available to all.